期刊文献+

拉米夫定耐药者体内乙型肝炎病毒水平与YMDD变异关系的研究 被引量:6

Studies on the Relationship between Hepatitis Virus level and YMDD Variation in Cases Resistant to Lamivudine
暂未订购
导出
摘要 目的 :探讨拉米夫定耐药者 YMDD变异类型、变异率及与体内病毒水平的关系。方法 :荧光定量 PCR检测拉米夫定耐药者血清 HBV-DNA浓度 ,PCR产物直接测序检测 YMDD变异情况。结果 :5 2例拉米夫定耐药者 YMDD变异检测结果 ,其中有 2 4例发生 YMDD变异 ,占 46.1 5 % ,并且 YMDD(酪氨酸、蛋氨酸、天门冬氨酸、天门冬氨酸 )基序发生三种变异 ,第一种类型为 YVDD变异 ,共有 1 1例 (变异率 2 1 .1 5 % ) ,即核苷酸 A741→ G变异 ;第二种类型为 YIDD变异 ,共有 1 1例(变异率 2 1 .1 5 % ) ,即核苷酸 G743→ T变异 ,其中有 1例核苷酸 G743→ C变异也引起 YIDD变异 ;第三种类型为 YLDD变异 ,共有 2例 (变异率 3 .85 % ) ,即核苷酸 A741→ T变异。 YMDD野生型血清病毒浓度为 7.0× 1 0 6± 1 .3× 1 0 6 copies/ ml,YVDD、YIDD、YLDD变异型病毒浓度分别为 7.5×1 0 6 ± 1 .5× 1 0 6 copies/ ml、7.6× 1 0 6 ± 1 .7× 1 0 6 copies/ ml、6.9× 1 0 6 ± 1 .3× 1 0 6 copies/ ml;经 t检验 ,YMDD变异型与 YMDD野生型血清病毒浓度之间的差异无显著性意义 (P>0 .0 5 )。结论 :除已报道的拉米夫定耐药者 YMDD基序发生 YVDD和 YIDD变异外 ,还存在 YLDD变异 ;拉米夫定耐药者体内乙肝病毒水平与发生 Objective: To explore the relationship between YMDD types,variation rates and viral levels in Lamivudine resistant cases.Methods:HBV-DNA was detected by using fluorescent quantitative PCR.PCR products Sequence was detected to see the YMDD variations.Results: Out of 52 Lamivudine resistant cases,YMDD variation happened in 24 cases (46.15%) with 3 types of variations:YVDD (11 cases,21.15%),nucleic acid A741 became G;YIDD (11 cases,21.15%),nucleic acid G743 became T; YLDD(2 cases,3.85%),nucleic acid A741 became T.Viral concentration in wild YMDD was 7×10 6 copies/ml,No difference was observed between them( P >0.05). Conclusion:At least 3 types of variation were observed in Lamivudine resistant cases and no relationship was observed between HBV-DNA level,YMDD types and variation rates.
出处 《浙江中西医结合杂志》 2002年第12期733-735,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
关键词 乙型肝炎病毒 拉米夫定 YMDD变异 荧光定量PCR 耐药 HBV Lamivudine YMDD variation Fluorescent quantitative PCR
  • 相关文献

参考文献2

二级参考文献3

  • 1Lai C L,Hepatology,1997年,25卷,241页
  • 2中华内科杂志,1995年,34卷,788页
  • 3王泰龄,中华肝脏病杂志,1998年,6卷,195页

共引文献55

同被引文献33

  • 1田园,杜绍财,张瑞,魏来,陈原,韩建德.拉米夫定治疗慢性乙型肝炎患者致YVDD变异的研究[J].中华肝脏病杂志,2005,13(6):455-456. 被引量:3
  • 2慢性乙型肝炎防治指南[J].中华传染病杂志,2005,23(6):421-431. 被引量:822
  • 3沈建坤,侯金林,周荣,杨红,许正锯,陈先礼,王崇国.乙型肝炎病毒三种基因分型方法的比较分析[J].中华肝脏病杂志,2006,14(8):620-622. 被引量:7
  • 4Zollner B, Petersen J, Puchhammer - Stockl E, et al. Viral features of lamivudine resistant hepatitis bgenotypes A and D [ J]. Hepatology, 2004,39 ( 1 ) :42 - 50.
  • 5Gutfreund KS, Willianms M, George R, et al. Genotypic succession of mutations of the hepatitis B virus polymerasc associated with lamivudine therapy[J]. J Hepatol,2000,33(10) :469 -475.
  • 6Dienstag JL,Goldin RD,Heathcote EJ,et al.Histological outcome during long-term lamivudine therapy.Castroenterology,2003,124(1):105-117.
  • 7Suzuki F,Tssubota A,Arase Y,et al.Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.Intervirology,2003,46(3):182-189.
  • 8Whalley SA,Brown D,Teo CG,et al.Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.J Clin Microbiol,2001,39(4):1456-1459.
  • 9Gutfreund KS,W illiams M,George R,et al.Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.J Hepatol,2000,33(3):469-475.
  • 10Chang ML,Chien RN,Yeh CT,et al.Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.J Hepatol,2005,43(1):72-77.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部